Home › MannKind shares rise 10% after insulin drug Afrezza OKd by FDA
 

Keywords :   


MannKind shares rise 10% after insulin drug Afrezza OKd by FDA

2014-07-01 05:02:03| Biotech - Topix.net

Afrezza is a powder insulin that is inhaled through a handheld device. A quick puff would replace an insulin injection that patients with diabetes now use to regulate blood glucose levels.

Tags: by drug rise shares

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
16.05'Time running out' plea over shipyard's future
16.05Eastern North Pacific Tropical Weather Outlook
16.05Atlantic Tropical Weather Outlook
16.05China's Nio unveils Tesla Model Y rival
16.05Could the US economy be doing too well?
16.05Eastern North Pacific Tropical Weather Outlook
16.05Atlantic Tropical Weather Outlook
16.05The man who turned his dead father into a chatbot
More »